Ameriprise’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-80,769
Closed -$4.5M 3860
2018
Q4
$4.5M Sell
80,769
-72,769
-47% -$3.95M ﹤0.01% 2190
2018
Q3
$7.13M Sell
153,538
-2,119
-1% -$103K ﹤0.01% 2121
2018
Q2
$7.51M Buy
155,657
+5,229
+3% +$250K ﹤0.01% 1961
2018
Q1
$6.51M Buy
150,428
+25,103
+20% +$1.13M ﹤0.01% 1985
2017
Q4
$4.98M Buy
125,325
+33,445
+36% +$1.39M ﹤0.01% 2144
2017
Q3
$3.99M Buy
+91,880
New +$4.19M ﹤0.01% 2247
2016
Q4
Sell
-130,453
Closed -$7.01M 3993
2016
Q3
$7.01M Buy
130,453
+23,801
+22% +$1.1M ﹤0.01% 1734
2016
Q2
$4.59M Buy
106,652
+290
+0.3% +$12.2K ﹤0.01% 2015
2016
Q1
$5.37M Buy
106,362
+864
+0.8% +$41.6K ﹤0.01% 1893
2015
Q4
$6.68M Sell
105,498
-86,954
-45% -$5.92M ﹤0.01% 1772
2015
Q3
$12.6M Buy
192,452
+91,082
+90% +$6.04M 0.01% 1269
2015
Q2
$6.86M Sell
101,370
-4,726
-4% -$261K ﹤0.01% 1912
2015
Q1
$4.53M Sell
106,096
-10,178
-9% -$453K ﹤0.01% 2162
2014
Q4
$5.75M Sell
116,274
-24,046
-17% -$963K ﹤0.01% 1965
2014
Q3
$4.03M Buy
140,320
+55,181
+65% +$1.5M ﹤0.01% 2159
2014
Q2
$2.23M Sell
85,139
-49,688
-37% -$1.28M ﹤0.01% 2495
2014
Q1
$7.51M Sell
134,827
-12,319
-8% -$709K ﹤0.01% 1751
2013
Q4
$7.08M Sell
147,146
-158,323
-52% -$6.66M ﹤0.01% 1754
2013
Q3
$12.8M Sell
305,469
-35,153
-10% -$1.67M 0.01% 1297
2013
Q2
$15.3M Buy
+340,622
New +$13.4M 0.01% 1148

Ameriprise's IMPV Position: Q1 2019 in Review

Ameriprise sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 80,769 shares — an estimated $4.5M sold.

Ameriprise first reported a position in IMPV in Q2 2013 and held it in 20 quarters. The position peaked at $15.3M in Q2 2013. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Ameriprise reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Ameriprise sold 80,769 Imperva, Inc. shares in Q1 2019, an estimated $4.5M.
  • Ameriprise first reported a position in Imperva, Inc. in Q2 2013 and held it in 20 quarters.
  • Ameriprise's Imperva, Inc. position peaked at $15.3M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Ameriprise's 13F filing for Q1 2019, filed 15 May 2019.